Imugene Health Care
Cancer Health Care Immunotherapy

$0.091 0.002 (2.25%)

High $0.10	Low $0.09	Trades 2,797	Turnover $4,713,392	Volume 50,159,971
30 June 2023 at 4:59pm

If you were already registered, log in here.

Market Cap (12-Nov) $19,392,378 (199th)	Close (30-Jun) $0.091 0 (0%)	Volume (30-Jun) 50,159,971	Shortsold (6-Nov) 1,815,355 (0.33%) (364th)
52w High $0.410	52w Low $0.030	P/E 13.30	EPS -0.32

Short Interest

ASIC data, 6 Nov 2026

% Shorted

0.33% 0.01

vs 0.34% prior report

Most Shorted Rank

364th

of 717 shorted ASX stocks

Peak Short

8.10%

Aug 2023

Days to Cover

0.6

at 50d avg vol

View full short position history →

	Subject
	IMU IMU Ann: Results of Meeting
	1 (current) 2 3
	IMU IMU Ann: AGM Presentation
	IMU IMU Ann: Imugene Investor Presentation
	IMU IMU Ann: Imugene onCARlytics with Estrella ARTEMIS T Cells SITC
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Dose escalates In Phase I Clinical Trial of New Oncolytic Vi
	IMU IMU Ann: Imugene onCARlytics with blinatumomab SITC presentation
	IMU IMU Ann: Imugene onCARlytics with Celularity CyCART-19 T Cells SITC
	IMU IMU Ann: Change of Director's Interest Notice - JE & CW
	IMU IMU Ann: AGM ATTENDANCE
	IMU IMU Ann: ALA: Europe Patent granted for iNKT Cell Therapy Platform
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: First patient dosed in VAXINIA intratumoral cohort 2
	IMU IMU Ann: Quarterly Activities/Appendix 4C Cash Flow Report
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Letter to IMUOC Optionholders
	IMU IMU Ann: Release of Shares from Escrow
	IMU IMU Ann: ABL and Imugene partner to advance VAXINIA manufacturing
	IMU IMU Ann: Notice of Annual General Meeting/Proxy Form
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: HERIZON study results to be featured at ESMO Asia Congress
	IMU IMU Ann: onCARlytics to be showcased in three abstracts at SITC
	IMU IMU Ann: Imugene appoints Paul Wright as Vice President CMC
	IMU IMU Ann: Imugene appoints Dr Giovanni Selvaggi as CMO
	IMU IMU Ann: ALA iNKT therapy and IMU onCARlytics - correction
	IMU IMU Ann: ALA: Investor Presentation Imugene Arovella Therapies
	IMU IMU Ann: Preclinical trial of ALA iNKT therapy and IMU onCARlytics
	IMU IMU Ann: First patient IV dosed in VAXINIA Phase 1 clinical trial
	IMU IMU Ann: Notification regarding unquoted securities - IMU
	IMU IMU Ann: Notice Under Section 708A
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: OGTR grants VAXINIA DIR licence allowing trial expansion
	IMU IMU Ann: Prospectus for the issue of institutional placement options
	IMU IMU Ann: Proposed issue of securities - IMU
	IMU IMU Ann: IMUGENE ANNOUNCES A$80 MILLION INSTITUTIONAL PLACEMENT
	IMU IMU Ann: Trading Halt
	IMU IMU Ann: Imugene doses first patient in nextHERIZON Phase 2 trial
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Initial Director's Interest Notice - JD
	IMU IMU Ann: Imugene appoints Dr Jakob Dupont as Non-Executive Director
	IMU IMU Ann: Application for quotation of securities - IMU
	IMU IMU Ann: Release of Shares from Escrow
	IMU IMU Ann: Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA
	IMU IMU Ann: Environmental Social and Governance (ESG) Report
	IMU IMU Ann: Corporate Governance Statement
	IMU IMU Ann: Appendix 4G
	IMU IMU Ann: Annual Report and Appendix 4E
	IMU IMU Ann: FIRST COHORT 3 PATIENT DOSED IN CLINICAL TRIAL OF CHECKVACC

If you were already registered, log in here.

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

Upcoming Floats (8)

SUPER MINERALS LTD

S88

MAVERICK URANIUM LIMITED

MAV

Capability X

CX8

MATRIX CRITICAL MINERALS LIMITED

MTX $12m raise

Fitgenes

ATW $7.5m raise

RIO DE ORO CORP LTD

RDO $30m raise

Adbri Ltd

ABC $5m raise

RAMSAY GENERALE DE SANTE SA

RGS

Top

End of Day Prices

Date	Close	Volume	Change
12-Nov	$0.04	750,930	+0.00 (2.94%)
11-Nov	$0.03	1,258,675	0.00 (5.56%)
10-Nov	$0.04	1,391,764	0.00 (5.26%)
09-Nov	$0.04	1,650,559	+0.00 (5.56%)
06-Nov	$0.04	1,475,944	+0.00 (2.86%)
05-Nov	$0.04	5,544,880	+0.01 (16.67%)
04-Nov	$0.03	5,928,012	0.00 (9.09%)
03-Nov	$0.03	197,738	0.00 (2.94%)
02-Nov	$0.03	707,327	0.00 (2.86%)
30-Oct	$0.04	2,873,391	0.00 (7.89%)
29-Oct	$0.04	898,785	+0.00 (8.57%)
28-Oct	$0.04	918,845	0.00 (2.78%)
27-Oct	$0.04	911,004	+0.00 (2.86%)
26-Oct	$0.04	1,881,028	0.00 (7.89%)
23-Oct	$0.04	2,122,778	0.00 (2.56%)
6 up, 9 down, and 0 flat days

Imugene Health Care
Cancer Health Care Immunotherapy

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Imugene Health Care Cancer Health Care Immunotherapy

Short Interest

Followers

Prices

Announcements

Similar Companies

Upcoming Floats (8)

End of Day Prices

Imugene Health Care
Cancer Health Care Immunotherapy